Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

dsRNA-Seq: Identification of Viral Infection by Purifying and Sequencing dsRNA.

Decker CJ, Steiner HR, Hoon-Hanks LL, Morrison JH, Haist KC, Stabell AC, Poeschla EM, Morrison TE, Stenglein MD, Sawyer SL, Parker R.

Viruses. 2019 Oct 14;11(10). pii: E943. doi: 10.3390/v11100943.

2.

Analysis of double-stranded RNA from microbial communities identifies double-stranded RNA virus-like elements.

Decker CJ, Parker R.

Cell Rep. 2014 May 8;7(3):898-906. doi: 10.1016/j.celrep.2014.03.049. Epub 2014 Apr 24.

3.

Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention.

Rao SC, Chhatriwalla AK, Kennedy KF, Decker CJ, Gialde E, Spertus JA, Marso SP.

J Am Coll Cardiol. 2013 May 7;61(18):1847-52. doi: 10.1016/j.jacc.2013.02.017. Epub 2013 Mar 7.

4.

P-bodies and stress granules: possible roles in the control of translation and mRNA degradation.

Decker CJ, Parker R.

Cold Spring Harb Perspect Biol. 2012 Sep 1;4(9):a012286. doi: 10.1101/cshperspect.a012286. Review.

5.

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809.

Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, Decker CJ, Miller M, McCartney J, Olson ER, Wine JJ, Frizzell RA, Ashlock M, Negulescu PA.

Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8. doi: 10.1073/pnas.1105787108. Epub 2011 Oct 5.

6.

Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space.

Reinen J, van Leeuwen JS, Li Y, Sun L, Grootenhuis PD, Decker CJ, Saunders J, Vermeulen NP, Commandeur JN.

Drug Metab Dispos. 2011 Sep;39(9):1568-76. doi: 10.1124/dmd.111.039461. Epub 2011 Jun 14.

PMID:
21673132
7.

Crystal structure of human Edc3 and its functional implications.

Ling SH, Decker CJ, Walsh MA, She M, Parker R, Song H.

Mol Cell Biol. 2008 Oct;28(19):5965-76. doi: 10.1128/MCB.00761-08. Epub 2008 Aug 4.

8.

Structural basis of dcp2 recognition and activation by dcp1.

She M, Decker CJ, Svergun DI, Round A, Chen N, Muhlrad D, Parker R, Song H.

Mol Cell. 2008 Feb 15;29(3):337-49. doi: 10.1016/j.molcel.2008.01.002.

9.
10.

CAR-1 and trailer hitch: driving mRNP granule function at the ER?

Decker CJ, Parker R.

J Cell Biol. 2006 Apr 24;173(2):159-63. Review.

11.

Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease.

Perni RB, Almquist SJ, Byrn RA, Chandorkar G, Chaturvedi PR, Courtney LF, Decker CJ, Dinehart K, Gates CA, Harbeson SL, Heiser A, Kalkeri G, Kolaczkowski E, Lin K, Luong YP, Rao BG, Taylor WP, Thomson JA, Tung RD, Wei Y, Kwong AD, Lin C.

Antimicrob Agents Chemother. 2006 Mar;50(3):899-909.

12.

Crystal structure and functional analysis of Dcp2p from Schizosaccharomyces pombe.

She M, Decker CJ, Chen N, Tumati S, Parker R, Song H.

Nat Struct Mol Biol. 2006 Jan;13(1):63-70. Epub 2005 Dec 11.

13.

Transanal excision of rectal villous adenomas by laparoscopic methods.

Decker CJ.

J Laparoendosc Adv Surg Tech A. 2005 Feb;15(1):23-7.

PMID:
15772472
14.

Crystal structure of Dcp1p and its functional implications in mRNA decapping.

She M, Decker CJ, Sundramurthy K, Liu Y, Chen N, Parker R, Song H.

Nat Struct Mol Biol. 2004 Mar;11(3):249-56. Epub 2004 Feb 1.

15.
16.

mRNA decay enzymes: decappers conserved between yeast and mammals.

Decker CJ, Parker R.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12512-4. Epub 2002 Sep 23. No abstract available.

17.
18.
19.

Prediction of pharmacokinetic properties using experimental approaches during early drug discovery.

Chaturvedi PR, Decker CJ, Odinecs A.

Curr Opin Chem Biol. 2001 Aug;5(4):452-63. Review.

PMID:
11470610
20.

The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.

Decker CJ, Heiser AD, Chaturvedi PR, Faust TJ, Ku G, Moseley S, Nimmesgern E.

Drugs Exp Clin Res. 2001;27(3):89-95.

PMID:
11447770
21.

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions.

Decker CJ, Laitinen LM, Bridson GW, Raybuck SA, Tung RD, Chaturvedi PR.

J Pharm Sci. 1998 Jul;87(7):803-7.

PMID:
9649346
22.

The exosome: a versatile RNA processing machine.

Decker CJ.

Curr Biol. 1998 Mar 26;8(7):R238-40. Review.

23.

Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts.

Decker CJ, Parker R.

Curr Opin Cell Biol. 1995 Jun;7(3):386-92. Review.

PMID:
7662369
25.

Editing domains of Trypanosoma brucei mitochondrial RNAs identified by secondary structure.

Piller KJ, Decker CJ, Rusché LN, Harris ME, Hajduk SL, Sollner-Webb B.

Mol Cell Biol. 1995 Jun;15(6):2916-24.

26.

Turnover mechanisms of the stable yeast PGK1 mRNA.

Muhlrad D, Decker CJ, Parker R.

Mol Cell Biol. 1995 Apr;15(4):2145-56.

27.

Mechanisms of mRNA degradation in eukaryotes.

Decker CJ, Parker R.

Trends Biochem Sci. 1994 Aug;19(8):336-40. Review.

PMID:
7940679
29.
30.

Pica in the mentally handicapped: a 15-year surgical perspective.

Decker CJ.

Can J Surg. 1993 Dec;36(6):551-4. Review.

PMID:
8258137
32.
33.

Metabolism of benzimidazoline-2-thiones by rat hepatic microsomes and hog liver flavin-containing monooxygenase.

Decker CJ, Doerge DR, Cashman JR.

Chem Res Toxicol. 1992 Sep-Oct;5(5):726-33.

PMID:
1446015
34.

Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes.

Decker CJ, Doerge DR.

Biochem Pharmacol. 1992 Feb 18;43(4):881-8.

PMID:
1371686
37.

An efficient method for the application of Avitene hemostatic agent.

Decker CJ.

Surg Gynecol Obstet. 1991 Jun;172(6):489.

PMID:
2035141
38.

RNA editing involves indiscriminate U changes throughout precisely defined editing domains.

Decker CJ, Sollner-Webb B.

Cell. 1990 Jun 15;61(6):1001-11.

PMID:
1693545
39.
40.

Maternal cell contamination mooted by amniocyte clones.

Bixenman HA, Manning MA, Decker CJ, Hecht BK, Hecht F.

Am J Med Genet. 1984 Apr;17(4):849-52. No abstract available.

PMID:
6720750

Supplemental Content

Loading ...
Support Center